William Blau

Clinical Cardiologist, Lipidologist, NYU Langone

[NYU CVD Prevention @NYUCVDPrevent]

Fellowship Opportunity! Accepting applications for our 1-year fellowship in preventive #cardiology.

The fellowship offers specialized training in primary & secondary #CVD prevention, including advanced lipid disorders, hypertension, thrombosis & more.⤵️

https://t.co/wYwpdEgSqb

[NYU CVD Prevention @NYUCVDPrevent]

Congratulations to Edward A. Fisher, MD, PhD, on being selected to deliver the Russell Ross Memorial Lectureship in Vascular Biology at #AHA26 this November in Chicago.

This well-deserved honor recognizes Dr. Fisher's exceptional contributions to vascular biology.

[NYU CVD Prevention @NYUCVDPrevent]

In Press Review! How does evinacumab fit into the treatment landscape for #HoFH? This new article, co-authored by Dr. James Underberg, reviews the evidence and provides practical guidance for clinicians⤵️

https://t.co/bAAOanEpTF

#knowfh

[NYU CVD Prevention @NYUCVDPrevent]

Join us Oct 9 (NYC/Virtual) for the 11th Annual Dietary & Lifestyle Strategies for Cardiovascular Risk Reduction CME Symposium.

Leading experts will unpack the latest #dyslipidemia and #dietary guidelines & what they mean for clinical practice.

https://t.co/ttJrNbqkev

[NYU CVD Prevention @NYUCVDPrevent]

On @NYUDocs today, our dietitian nutritionist Jordyn Fantuzzi shared a key takeaway: simple changes can make a big impact on #hearthealth.

🥗 Fill half your plate with non-starchy vegetables
🏠 Cook one more dinner at home each week
🚶 Make routine exercise a habit

[NYU CVD Prevention @NYUCVDPrevent]

Could blood based multiomic profiling improve risk stratification in chronic coronary disease? NYU Grossman #ISCHEMIA investigators report molecular subtypes linked to future CV events beyond traditional risk scores, with potential to personalize treatment https://t.co/5OhXPEdemp

[NYU CVD Prevention @NYUCVDPrevent]

We’re thrilled to welcome Dr. Joshua Hyman as our newest Preventive Cardiology Fellow-the 17th fellow in our program’s history!

Dr. Hyman earned his medical degree at Yale and recently completed the Yale Internal Medicine-Pediatrics Residency Program.

https://t.co/xGk0gbyIWs

[NYU CVD Prevention @NYUCVDPrevent]

Proud to be named by @healthcentral as one of its 10 Centers of Excellence in Cardiovascular Care.

The report recognizes our Center's multidisciplinary approach & specialized programs, including Cardio-Rheumatology and Postpartum Cardiovascular Health.

https://t.co/MRJlDQiN8r

[National Lipid Association @nationallipid]

The 2026 #NLASessions is officially underway, and we couldn’t have asked for a better start to our time in Chicago!

We kicked off the day by wrapping up our three pre-conference courses before diving into a full agenda of learning and connection. The day continued with two Expert Theaters and the Opening Session before ending at the Welcome Reception, where our incredible lipid community got to reconnect.

Tomorrow’s schedule is just as exciting, with @VindicoMedEd’s breakfast symposium, gene editing, Late Breakers, the NLA/EAS Joint Session, and much more on deck.

Rest up and get ready for another action-packed day at #NLASessions!

[Roger Blumenthal @rblument1]

The Preventive Cardiology community mourns the passing of a legendary educator & highly skilled clinician, Dr. Howard Weintraub. His sense of humor was present in every lecture that he gave. Some of us referred to him as the Jackie Mason Professor of 🫀. We will greatly miss him.

[NYU CVD Prevention @NYUCVDPrevent]

📣New in AJPC: AHA #Lipoprotein(a) Discovery Project

Congrats to Dr. Howard Weintraub and colleagues on this publication! This 3 year project was instrumental in developing foundational clinician & patient education resources to advance #LPA awareness.

https://t.co/UInu7jjUum

[William Blau @blau_william]

@NYUCVDPrevent @nationallipid @MarkSteuerwald @lipiddoc @PlateletDoc @garshick @heffron_sean @CarineHamo @ChiaraGiannare1 Great news!!

[NYU CVD Prevention @NYUCVDPrevent]

Congrats to Dr. Mark Steuerwald our preventive cardiology fellow, on passing the lipid boards (@nationallipid).

Becoming a Diplomate of the American Board of Clinical Lipidology is the highest benchmark of professional competency in Clinical Lipidology.

Well deserved! 👏

[NYU CVD Prevention @NYUCVDPrevent]

Why are #PCSK9 inhibitors still underutilized?

Join leading lipid expert Dr. James Underberg to explore how PCSK9 inhibitors can help patients with ASCVD, HeFH, & HoFH #knowFH achieve LDL-C goals that have remained out of reach with standard therapies.

��https://t.co/Cr3AAx5Hvt

[NYU CVD Prevention @NYUCVDPrevent]

How are ANGPTL3 & ApoC3 therapies reshaping the triglyceride story?

Join renowned lipid expert Dr. Daniel Soffer as he unpacks ApoC3 & ANGPTL3/4 inhibition & highlights their safety/efficacy in reducing #cardiovascular risk.

Sign up (NYC/livestream): https://t.co/Cr3AAx59FV

[William Blau @blau_william]

@Matt_Pinner 18

[Jonathan Reiner @JReinerMD]

Here’s my eulogy from today for Vice President Dick Cheney.

[NYU CVD Prevention @NYUCVDPrevent]

Today at #AHA25: Stop by Clinical Science Zone 2 to hear Dr. Carine Hamo report on premature discontinuation or downtitration of #heartfailure GDMT after changes in kidney function.

Sunday, 11/9
11:30AM–12:30PM
Session: AI, Digital Health and Remote Monitoring on the HF Horizon

[NYU CVD Prevention @NYUCVDPrevent]

How does aggressive #lipid lowering affect vascular endothelium in #diabetic vs healthy individuals?

➡️Sun, 11/9 (11:50-11:55 AM) at #AHA25

Stop by moderated digital poster 13 (PL.MDP.09) to hear findings from the Cardiometabolic Health Strategically Focused Research Network.

[NYU CVD Prevention @NYUCVDPrevent]

@garshick @PlateletDoc @nyugrossman @nyuendocrine @NYULH_DeptofMed @lipiddoc @blau_william @CarineHamo Kudos to Dr. Michael Garshick & Colleauges on a terrific #AHA25 moderated poster session! 🎉